Clinical Trial Update: Neo-Adjuvant FOLFOX for Rectal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of neoadjuvant FOLFOX for rectal cancer was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Rectal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2013-04-22